Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100B | P04271 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | BRPF1 | P55201 | 11/20 | 0.40 |
| ▸ | BRD1 | O95696 | 9/20 | 0.40 |
| ▸ | BRPF3 | Q9ULD4 | 2/20 | 0.39 |
| ▸ | BRD4 | O60885 | 2/20 | 0.39 |
| ▸ | CCR4 | P51679 | 1/20 | 0.39 |
| ▸ | TRIM24 | O15164 | 9/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanide SCHEMBL25408115 | 0.81 | ATAD2 (0.49) | S100BALDH1A1BRPF1BRD1BRD4 | |
| Cyanide SCHEMBL25405305 | 0.79 | PARG (0.38) | S100BALDH1A1BRPF1BRD1BRD4 | |
| Cyanide SCHEMBL25407373 | 0.79 | ATAD2 (0.37) | S100BALDH1A1BRPF1BRD1BRD4 | |
| Cyanide SCHEMBL25406481 | 0.77 | S100B (0.42) | S100BALDH1A1BRPF1BRD1BRPF3 | |
| SCHEMBL11634100 | 0.77 | S100B (0.59) | S100BALDH1A1BRPF1BRD1BRPF3 | |
| Cyanide SCHEMBL22130246 | 0.72 | ALDH1A1 (0.57) | ALDH1A1BRPF1BRD4MAPTKMT2A | |
| SCHEMBL2318213 | 0.70 | KDM4E (0.54) | ALDH1A1MAPTKMT2AKDM4EGAA | |
| SCHEMBL21966239 | 0.69 | S100B (0.57) | S100BALDH1A1BRPF1BRD1BRPF3 | |
| SCHEMBL28977431 | 0.68 | S100B (0.65) | S100BALDH1A1BRPF1BRD1BRPF3 | |
| SCHEMBL26654511 | 0.66 | S100B (0.62) | S100BALDH1A1BRPF1BRD1BRPF3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230295095-A1 | NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-09-21 | — | — | US | claimed |
| EP-4169905-A1 | NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF | Korea Institute of Science and Technology (KR) | 2023-04-26 | — | — | EP | claimed |
| US-20230295095-A1 | NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-09-21 | — | — | US | disclosed |
| EP-4169905-A1 | NOVEL FUSED HETEROCYCLIC CARBONOHYDRAZONOYL DICYANIDE COMPOUND AND USE THEREOF | Korea Institute of Science and Technology (KR) | 2023-04-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230295095-A1 | NOVEL FUSED-HETEROCYCLYL-CARBONOHYDRAZONOYL DICYANIDE COMPOUNDS AND USE THEREOF | CBR3, DBF4, DDT | S100B 4221/4885ALDH1A1 1343/4885BRPF1 3211/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.